AMPLY Discovery Limited

AMPLY Discovery Limited, a UK-based AI-driven drug discovery company, has announced a strategic investment from Keeps Biomed, a subsidiary of South Korean specialist biotech company Keeps Biopharma.

Summary of transaction details:

• Value: Not Disclosed
• Sector: Healthcare & Biotech
• Advisor: Not Disclosed
• Key Entities: AMPLY Discovery Limited, Keeps Biomed
• Location: UK, South Korea

Note: This investment is expected to drive future collaboration opportunities in oncology and highlights the growing importance of strategic partnerships in the biotech industry.